Fiera Capital (Canada)
PPH icon

Fiera Capital (Canada)’s VanEck Pharmaceutical ETF PPH Stock Holding History

Fiera Capital (Canada)’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,000
Closed -$630K – 734
2016
Q4 		$630K Buy
+12,000
New +$641K ﹤0.01% 625

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SCM
Stuyvesant Capital Management Armonk, New York $41.1M AUM 17.11% 1-Year Est. Return
CC
Colrain Capital Boston, Massachusetts $259M AUM 63.6% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fiera Capital (Canada)'s PPH Position: Q1 2017 in Review

Fiera Capital (Canada) sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2017, closing a stake of 12,000 shares — an estimated $630K sold.

Fiera Capital (Canada) first reported a position in PPH in Q4 2016 and held it in 1 quarter. The position peaked at $630K in Q4 2016. 50 funds tracked by Wall St. Rank hold PPH as of Q1 2017.

  • Fiera Capital (Canada) reported no remaining VanEck Pharmaceutical ETF position as of Q1 2017 after selling out during the quarter.
  • Fiera Capital (Canada) sold 12,000 VanEck Pharmaceutical ETF shares in Q1 2017, an estimated $630K.
  • Fiera Capital (Canada) first reported a position in VanEck Pharmaceutical ETF in Q4 2016 and held it in 1 quarter.
  • Fiera Capital (Canada)'s VanEck Pharmaceutical ETF position peaked at $630K in Q4 2016.
  • 50 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2017.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2017, filed 15 May 2017.